Neuroendocrine tumors in the Iran Cancer Institute: Predictive Factors of Patient Survival |
Sadighi, Sanambar
(Department of Internal Medicine, Cancer Research Center, Tehran University of Medical Sciences)
Roshanaee, Ghodratollah (Biostatistics Department, Hamadan University of Medical Sciences) Vahedi, Saba (Department of Internal Medicine, Cancer Research Center, Tehran University of Medical Sciences) Jahanzad, Easa (Department of Pathology, Cancer Research Center, Tehran University of Medical Sciences) Mohagheghi, Mohammad Ali (Department of Surgical Oncology, Cancer Research Center, Tehran University of Medical Sciences) Mousavi-Jarahi, Alireza (Department of Social Medicine, Shahid Beheshti University of Medical Sciences) |
1 | Al-khafaji B, Noffsinger A, Miller M, et al (1999). Immunohistologic analysis of GI and pulmonary carcinoid tumors. Hum Pathol, 29, 992. |
2 | Bernick P, Klimstra S, Shia Jea (2004). Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum, 47, 163-9. DOI ScienceOn |
3 | Brenner B, Shah M, Gonen M (2004). Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. Br J Cancer, 90, 1720-6. |
4 | Galanis E, Frytak S, Lloyd R (1997). Extrapulmonary small cell carcinoma. Cancer, 79, 1729-36. DOI |
5 | Demirci U, Coskun U, Karaca H, et al (2014). Docetaxel and cisplatin in first line treatment of patients with unknown primary cancer: a multicenter study of the Anatolian Society of Medical Oncology. Asian Pac J Cancer Prev, 15, 1581-4. 과학기술학회마을 DOI ScienceOn |
6 | Durante C, Boukheris H, Dromain C, et al (2009). Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma. Endocr Relat Cancer, 16, 585-97. DOI ScienceOn |
7 | Fujii H, Aotake T, Horiuchi T et al (2001). Small cell carcinoma of the gallbladder: a case 45 report and review of 53 cases in the literature. Hepatogastroenterology, 48, 1588-93. |
8 | Garcia-Carbonero R, Capdevila J, Crespo-Herrero G (2010). Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the national cancer registry of Spain (RGETNE). Ann Oncol, 21, 1794-803. DOI ScienceOn |
9 | Harkema J, Jones S, Naydan D, Wilson D (1992). An atypical neuroendocrine carcinoma in the lung of a beagle dog. Vet Pathol, 29, 175-9. DOI ScienceOn |
10 | Junker K, Wiethege T, Muller K (2000). Pathology of small-cell lung cancer. J cancer Res clin oncol, 7, 361-8. |
11 | Kang H, O'Connell J, Leonardi M (2007). Rare tumors of the colon and rectum: a national review. Int J Colorectal Dis, 22, 183-9. |
12 | Kulve M, Mayer R (1999). Carcinoid tumors. N Engl J Med, 340, 858-68. DOI ScienceOn |
13 | Lee S, Lee J, Ryu M (2007). Extrapulmonary small cell carcinoma: single center experience with 61 patients. Acta Oncol, 46, 846-51. DOI ScienceOn |
14 | Moertel C, Kvols L, O'Connell M (1991). Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin: evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer, 68, 227-32. DOI |
15 | Medrano-Guzman R, Lopez-Garcia SC, Torres-Vargas S, Gonzalez-Rodriguez D, Alvarado-Cabrero I (2011). Resectability of primary gastroenteropancreatic neuroendocrine tumor as a prognostic factor for survival. Cirugia y Cirujanos, 79, 459-564. |
16 | Modlin I, Lye K, Kidd M (2003). A 5-decade analysis of 13, 715 carcinoid tumors. Cancer, 97, 934-59. DOI ScienceOn |
17 | Modlin I, Oberg K, Chung D, et al (2008). Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol, 9, 61-72. DOI ScienceOn |
18 | Wang Y-h, Lin Y, Xue L, et al (2012). Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: A single-institution analysis (1995-2012) in South China. BMC Endocr Disord, 12, 30-9. DOI ScienceOn |
19 | Sadighi S, Jahanzad I, Ghadirian L, et al (2013). Assessing the prevalence and characteristics of neuroendocrine tumors in patients attending Tehran Imam Khomeiny referral hospital. J Mazand Univ Med Sci, 23, 232-6. |
20 | Sorbye H, Welin S, Langer SW, et al (2013). Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study. Ann Oncol, 24, 152-60. DOI ScienceOn |
21 | Wu B, Hu Y, Sun J, et al (2014). Analysis on the characteristics and prognosis of pulmonary neuroendocrine tumors. Asian Pac J Cancer Prev, 15, 2205-10. 과학기술학회마을 DOI ScienceOn |
22 | Yao J, Hassan M, Phan A, et al (2008). One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol, 26, 3063-72. DOI ScienceOn |
23 | Yocel B, Babakan NAKanan T, Ayeren A (2013). Survival analysis and prognostic factors for neuroendocrine tumors in Turkey. Asian Pac J Cancer Prev, 14, 6687-92. 과학기술학회마을 DOI ScienceOn |
24 | Zeng YJ, Liv L, We H, et al (2013). Clinicopathologic features and prognosis of GIP neuroendocrine tumors:Analysis from a single institution. Asian Pac J Cancer Prev, 14, 5775-81. DOI ScienceOn |
![]() |